Tocolytics for preterm labor: A systematic review

Obstetrics and Gynecology

Volumn 94, Issue 5 SUPPL. 1, 1999, Pages 869-877

  Gyetvai, Kristen ^a,b   Hannah, Mary E ^a,b   Hodnett, Ellen D ^b   Ohlsson, Arne ^b  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATOSIBAN; CALCIUM ANTAGONIST; GLYCERYL TRINITRATE; HEXOPRENALINE; INDOMETACIN; ISOXSUPRINE; MAGNESIUM SULFATE; NIFEDIPINE; OXYTOCIN ANTAGONIST; PLACEBO; PROSTAGLANDIN SYNTHASE INHIBITOR; RITODRINE; SULINDAC; TERBUTALINE; UTERUS SPASMOLYTIC AGENT;

CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LITERATURE; META ANALYSIS; PERINATAL PERIOD; PREMATURE LABOR; PRIORITY JOURNAL; REVIEW; TOCOLYSIS;

CLINICAL TRIALS; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; PREGNANCY; TOCOLYTIC AGENTS;

EID: 0032860696     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(99)00329-4     Document Type: Review

References (79)

1. Hack M., Merkatz I.R. Preterm delivery and low birth weight - a dire legacy. N Engl J Med. 333:1995;1772-1774.
2. Joseph K.S., Kramer M.S., Marcoux S., Ohlsson A., Wen S.W., Allen A., et al. Determinants of preterm birth rates in Canada from 1981 through 1983 and from 1992 through 1994. N Engl J Med. 339:1998;1434-1439.
3. Copper R.L., Goldenberg R.L., Creasy R.K., DuBard M.B., Davis R.O., Entman S.S., et al. A multicenter study of preterm birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol. 168:1993;78-84.
4. Higby K., Xenakis E.M., Pauerstein C.J. Do tocolytic agents stop preterm labor? A critical and comprehensive review of efficacy and safety. Am J Obstet Gynecol. 168:1993;1247-1259.
5. Mulrow CD, Oxman AD, eds. Cochrane collaboration handbook [updated September 1997]. In: The Cochrane library [database on disk and CDROM]. The Cochrane Collaboration. Oxford: Update Software, 1998, Issue 1.
6. Hesseldahl H. A Danish multicenter study on ritodrine in the treatment of preterm labour. Dan Med Bull. 26:1979;116-118.
7. Kristoffersen K., Hansen M.K. The condition of the foetus and infant in cases treated with ritodrine. Dan Med Bull. 26:1979;121-122.
8. Wesselius-De Casparis A., Thiery M., Yo Le Sian A., Baumgarten K., Brosens I., Gamisans O., et al. Results of double-blind, multicentre study with ritodrine in premature labour. BMJ. 3:1971;144-147.
9. Walters W.A., Wood C. A trial of oral ritodrine for the prevention of premature labour. Br J Obstet Gynaecol. 84:1977;26-30.
10. Christensen K.K., Ingemarsson I., Leideman T., Solum H., Svenningsen N. Effect of ritodrine on labor after premature rupture of the membranes. Obstet Gynecol. 55:1980;187-190.
11. Leake R.D., Hobel C.J., Oh W., Thibeault D.W., Okada D.W. A controlled, prospective study of the effect of ritodrine hydrochloride for premature labor. Pediatr Res. 14:1980;603.
12. Guinn D.A., Goepfert A.R., Owen J., Brumfield C., Hauth J.C. Management options in women with preterm uterine contractions A randomized clinical trial . Am J Obstet Gynecol. 177:1997;814-818.
13. Dunlop P.D.M., Crowley P.A., Lamong R.F., Hawkins D.F. Preterm ruptured membranes, no contractions. J Obstet Gynaecol. 7:1986;92-96.
14. Osler M. Side effects and metabolic changes during treatment with betamimetics (ritodrine). Dan Med Bull. 26:1979;119-120.
15. Howard T.E. Jr, Killam A.P., Daniell W.C. A double blind randomized study of terbutaline in premature labor. Mil Med. 147:1982;305-307.
16. th Study Group of the RCOG. 1985;209-218 RCOG, London, UK.
17. Weiner C.P., Renk K., Klugman M. The therapeutic efficacy and cost-effectiveness of aggressive tocolysis for premature labor associated with premature rupture of the membranes. Am J Obstet Gynecol. 159:1988;216-222.
18. Larsen J.F., Eldon K., Lange A.P., Leegaard M., Osler M., Olsen J.S., et al. Ritodrine in the treatment of preterm labor Second Danish multicenter study . Obstet Gynecol. 67:1986;607-613.
19. Levy D.L., Warsof S.L. Oral ritodrine and preterm premature rupture of membranes. Obstet Gynecol. 66:1985;621-623.
20. O'Conner M.C., Murphy H., Dalrymple I.J. Double blind trial of ritodrine and placebo in twin pregnancy. Br J Obstet Gynaecol. 86:1979;706-709.
21. Brown S.M., Tejani N.A. Terbutaline sulfate in the prevention of recurrence of premature labor. Obstet Gynecol. 57:1981;22-25.
22. Ashworth M.F., Spooner S.F., Verkuyl A.A., Waterman R., Ashurst H.M. Failure to prevent preterm labour and delivery in twin pregnancy using prophylactic oral salbutamol. Br J Obstet Gynaecol. 97:1990;878-882.
23. Creasy R.K., Golbus M.S., Laros R.K. Jr, Parer J.T., Roberts J.M. Oral ritodrine maintenance in the treatment of preterm labor. Am J Obstet Gynecol. 137:1980;212-219.
24. Parilla B.V., Dooley S.I., Minogue J.P., Min D., Socol M.L. The efficacy of oral terbutaline after intravenous tocolysis. Am J Obstet Gynecol. 169:1993;965-969.
25. Carlan S.J., O'Brien W.F., Jones M.H., O'Leary T.D., Roth L. Outpatient oral sulindac to prevent recurrence of preterm labor. Obstet Gynecol. 85:1995;769-774.
26. Rust O.A., Bofill J.A., Arriola R.M., Andrew M.E., Morrison J.C. The clinical efficacy of oral tocolytic therapy. Am J Obstet Gynecol. 175:1996;838-842.
27. Lewis R., Mercer B.M., Salama M., Walsh M.A., Sibai B.M. Oral terbutaline after parenteral tocolysis A randomized, double-blind, placebo-controlled trial . Am J Obstet Gynecol. 175:1996;834-837.
28. Hagay Z.J., Epstein M., Goldchmit R., Gotlib Z., Blickstein I., Zalel Y., et al. A prospective randomized clinical trial comparing a new oral sustained-release ritodrine versus conventional ritodrine tablets. Eur J Obstet Gynecol Reprod Biol. 56:1994;83-87.
29. Das R.K. Isoxuprine in premature labour. J Obstet Gynecol India. 19:1969;566-570.
30. Csapo A.I., Herczeg J. Arrest of premature labor by isoxsuprine. Am J Obstet Gynecol. 129:1977;482-491.
31. Adkins R.T., Van Hooydonk J.E., Bressman P.L., Growdon J.H. Jr, Bolen P.R., Varin J.C., et al. Prevention of preterm birth Early detection and aggressive treatment with terbutaline . South Med J. 86:1993;157-164.
32. Murray C., Haverkamp A.D., Orleans M., Berga S., Pecht D. Nifedipine for treatment of preterm labor A historic prospective study . Am J Obstet Gynecol. 167:1992;52-56.
33. Erny R., Pigne A., Prouvost C., Gamerre M., Malet C., Serment H., et al. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol. 154:1986;525-529.
34. McGregor J., French J.I., Seo K. Adjunctive clindamycin therapy for preterm labor Results of a double-blind, placebo-controlled trial . Am J Obstet Gynecol. 165:1991;867-875.
35. Morales W.J., Angel J.L., O'Brien W.F., Knuppel R.A., Finazzo M. A randomized study of antibiotic therapy in idiopathic preterm labor. Obstet Gynecol. 72:1988;829-833.
36. Newton E.R., Dinsmoor M.J., Gibbs R.S. A randomized, blinded, placebo-controlled trial of antibiotics in idiopathic preterm labor. Obstet Gynecol. 74:1989;562-566.
37. McGregor J.A., French J.I., Reller L.B., Todd J.K., Makowski E.L. Adjunctive erythromycin treatment for idiopathic preterm labor Results of a randomized, double-blinded, placebo-controlled trial . Am J Obstet Gynecol. 154:1986;98-103.
38. Gordon M., Samuels P., Shubert P., Johnson F., Gebauer C., Iams J. A randomized, prospective study of adjunctive ceftizoxime in preterm labor. Am J Obstet Gynecol. 172:1995;1546-1552.
39. Norman K., Pattinson R.C., de Souza J., de Jong P., Moller G., Kirsten G. Ampicillin and metronidazole treatment in preterm labour A multicentre, randomised controlled trial . Br J Obstet Gynaecol. 101:1994;404-408.
40. Lockwood C.J., Costigan K., Ghidini A., Wein R., Chien D., Brown B.L., et al. Double-blind, placebo-controlled trial of piperacillin prophylaxis in preterm membrane rupture. Am J Obstet Gynecol. 169:1993;970-976.
41. McCaul J.F., Perry K.G. Jr, Moore J.L. Jr, Martin R.W., Bucovaz E.T., Morrison J.C. Adjunctive antibiotic treatment of women with preterm rupture of membranes or preterm labor. Int J Gynecol Obstet. 38:1992;19-24.
42. Kurki T., Hallman M., Zilliacus R., Teramo K., Ylikorkala O. Premature rupture of the membranes Effect of penicillin prophylaxis and long-term outcome of the children . Am J Perinat. 9:1992;11-16.
43. Christmas J.T., Cox S.M., Andrews W., Dax J., Leveno K.J., Gilstrap L.C. Expectant management of preterm ruptured membranes Effects of antimicrobial therapy . Obstet Gynecol. 80:1992;759-762.
44. McGregor J.A., French J.I., Seo K. Antimicrobial therapy in preterm premature rupture of membranes Results of a prospective, double-blind, placebo-controlled trial of erythromycin . Am J Obstet Gynecol. 165:1991;632-640.
45. Romero R., Sibai B., Caritis S., Paul R., Depp R., Rosen M., et al. Antibiotic treatment of preterm labor with intact membranes A multicenter, randomized, double-blinded, placebo-controlled trial . Am J Obstet Gynecol. 169:1993;764-774.
46. Thomsen A.C., Morup L., Hansen K.B. Antibiotic elimination of group-B streptococci in urine in prevention of preterm labor. Lancet. 1:1987;591-593.
47. Amon E., Lewis S.V., Sibai B.M., Villar M.A., Arheart K.L. Ampicillin prophylaxis in preterm premature rupture of the membranes A prospective randomized study . Am J Obstet Gynecol. 159:1988;539-543.
48. Newton E.R., Shields L., Ridgway L.E. 3rd, Berkus M.D., Elliott B.D. Combination antibiotics and indomethacin in idiopathic preterm labor A randomized double-blind clinical trial . Am J Obstet Gynecol. 165:1991;1753-1759.
49. Winkler M., Baumann L., Ruckhaberle K.E., Schiller E.M. Erythromycin therapy for subclinical intrauterine infections in threatened preterm delivery - A preliminary report. J Perinat Med. 16:1988;253-256.
50. Morales W.J., Angel J.L., O'Brien W.F., Knuppel R.A. Use of ampicillin and corticosteroids in premature rupture of membranes A randomized study . Obstet Gynecol. 73:1989;721-726.
51. Johnston M.M., Sanchez-Ramos L., Vaughn A.J., Todd M.W., Benrubi G.I. Antibiotic therapy in preterm premature rupture of membranes A randomized, prospective, double-blind trial . Am J Obstet Gynecol. 163:1990;743-747.
52. Mercer B.M., Moretti M.L., Prevost R.R., Sibai B.M. Erythromycin therapy in preterm premature rupture of the membranes A prospective, randomized trial of 220 patients . Am J Obstet Gynecol. 166:1992;794-802.
53. Merkatz I.R., Peter J.B., Barden T.P. Ritodrine hydrochloride A betamimetic agent for use in preterm labor. II. Evidence of efficacy . Obstet Gynecol. 56:1980;7-12.
54. Penny L.L., Daniell W.C. Estimation of success in treatment of premature labor Applicability of prolongation index in a double-blind, controlled randomized trial . Am J Obstet Gynecol. 138:1980;345-346.
55. Kullander S., Svanberg L. On resorption and the effects of vaginally administered terbutaline in women with premature labor. Acta Obstet Gynecol Scand. 64:1985;613-616.
56. Goodwin T.M., Paul R., Silver H., Spellacy W., Parsons M., Chez R., et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol. 170:1994;474-478.
57. Zuckerman H., Shalev E., Gilad G., Katzuni E. Further study of the inhibition of premature labor by indomethacin. Part II double-blind study. J Perinat Med. 12:1984;25-29.
58. Niebyl J.R., Blake D.A., White R.D., Kumor K.M., Dubin N.H., Robinson J.C., et al. The inhibition of premature labor with indomethacin. Am J Obstet Gynecol. 136:1980;1014-1019.
59. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med. 327:1992;308-312.
60. Fox M.D., Allbert J.R., McCaul J.F., Martin R.W., McLaughlin B.N., Morrison J.C. Neonatal morbidity between 34 and 37 weeks' gestation. J Perinatol. 13:1993;349-353.
61. Garite T.J., Keegan K.A., Freeman R.K., Nageotte M.P. A randomized trial of ritodrine tocolysis versus expectant management in patients with premature rupture of membranes at 25 to 30 weeks of gestation. Am J Obstet Gynecol. 157:1987;388-393.
62. Cotton D.B., Strassner H.T., Hill L.M., Schifrin B.S., Paul R.H. Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor. A randomized study. J Reprod Med. 29:1984;92-97.
63. Spellacy W.N., Cruz A.C., Birk S.A., Buhi W.C. Treatment of premature labor with ritodrine A randomized controlled study . Obstet Gynecol. 54:1979;220-223.
64. Leveno K.J., Klein V.R., Guzick D.S., Young D.C., Hankins G.D., Williams M.L. Single-centre randomized trial of ritodrine hydrochloride for preterm labour. Lancet. 1:1986;1293-1296.
65. Larsen J.F., Hansen M.K., Hesseldahl H., Kristoffersen K., Larsen P.K., Osler M., et al. Ritodrine in the treatment of preterm labour. A clinical trial to compare a standard treatment with three regimens involving the use of ritodrine. Br J Obstet Gynaecol. 87:1980;949-957.
66. Adam S.G. Isoxuprine and preterm labour. Aust N Z J Obstet Gynaecol. 6:1966;294-298.
67. Zlatnik F.J., Fuchs F. A controlled study of ethanol in threatened premature labor. Am J Obstet Gynecol. 112:1972;610-612.
68. Ingemarsson I. Effect of terbutaline on premature labor A double-blind placebo-controlled study . Am J Obstet Gynecol. 125:1976;520-524.
69. Cox S.M., Sherman M.L., Leveno K.J. Randomized investigation of magnesium sulfate for prevention of preterm birth. Am J Obstet Gynecol. 163:1990;767-772.
70. Mittendorf R., Covert R., Boman J., Khoshnood B., Lee K.S., Siegler M. Is tocolytic magnesium sulfate associated with increased total paediatric mortality? Lancet. 350:1997;1517-1518.
71. Keirse MJNC. Betamimetic tocolytics in preterm labour. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, eds. Pregnancy & childbirth module. Cochrane database of systematic reviews. Oxford: Update Software, 1995, Issue 2.
72. King J.F., Grant A., Keirse M.J., Chalmers I. Beta-mimetics in preterm labour An overview of the randomized controlled trials . Br J Obstet Gynaecol. 95:1988;211-222.
73. Hannah M., Amankwah K., Barret J., Bonin B., Burrows R., Cheng M., et al. The Canadian consensus on the use of tocolytics for preterm labour. J SOGC. 17:1995;1089-1115.
74. Schendel D.E., Berg C.J., Yeargin-Allsopp M., Boyle C.A., Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low birth weight children aged 3 to 5 years. JAMA. 276:1996;1805-1810.
75. Nelson K.B., Grether J.K. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics. 95:1995;263-269.
76. Eronen M., Pesonen E., Kurki T., Teramo Ylikorkala O., Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr. 124:1994;782-788.
77. Showstack J.A., Stone M.H., Schroeder S.A. The role of changing clinical practices in the rising costs of hospital care. N Engl J Med. 313:1985;1201-1207.
78. Main D.M. The epidemiology of preterm birth. Clin Obstet Gynecol. 13:1988;521-532.
79. Iams J.D. Current status of prematurity prevention. JAMA. 262:1989;265-266.